Valuation: Hologic, Inc.

Capitalization 17.2B 16.26B 15.08B 13.45B 24.29B 1,460B 26.61B 187B 69.22B 599B 64.59B 63.18B 2,598B P/E ratio 2024
24.5x
P/E ratio 2025 * 21.6x
Enterprise value 17.26B 16.31B 15.13B 13.5B 24.37B 1,464B 26.7B 188B 69.45B 601B 64.81B 63.4B 2,607B EV / Sales 2024
4.74x
EV / Sales 2025 * 3.95x
Free-Float
75.95%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.62%
1 week-0.49%
Current month-3.03%
1 month-2.90%
3 months-5.94%
6 months+4.22%
Current year+7.89%
More quotes
1 week
74.44
Extreme 74.44
80.31
1 month
74.44
Extreme 74.44
80.31
Current year
70.53
Extreme 70.53
84.67
1 year
68.15
Extreme 68.15
84.67
3 years
59.78
Extreme 59.78
87.88
5 years
26.49
Extreme 26.49
87.88
10 years
25.26
Extreme 25.26
87.88
More quotes
Director TitleAgeSince
Chief Executive Officer 60 06/12/2013
Director of Finance/CFO 54 31/07/2018
Chief Operating Officer 44 31/12/2023
Manager TitleAgeSince
Director/Board Member 70 21/10/2007
Director/Board Member 53 31/10/2011
Director/Board Member 73 05/05/2013
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.62%-0.49%+12.24%+3.13%17.2B
+0.18%+0.72%+8.74%-16.23%205B
+0.28%-0.22%+71.35%+56.69%192B
+0.03%-1.97%+6.68%-25.63%170B
+0.82%-0.95%+62.16%+117.66%131B
+2.22%+3.52%+2.37%-20.33%62B
+1.20%-0.09%-11.16%-29.12%43.27B
+3.91%+4.89%+4.72%-39.57%41.82B
-0.17%+3.00%+11.23%-8.19%41.07B
+0.74%+0.13%+16.24% - 37.42B
Average +1.01%-0.47%+18.46%+4.27% 94.13B
Weighted average by Cap. +0.59%-0.68%+27.51%+15.61%
See all sector performances

Financials

2024 2025 *
Net sales 4.02B 3.8B 3.52B 3.14B 5.68B 341B 6.22B 43.82B 16.18B 140B 15.1B 14.77B 607B 4.18B 3.95B 3.66B 3.27B 5.9B 355B 6.46B 45.54B 16.81B 145B 15.69B 15.35B 631B
Net income 803M 759M 704M 628M 1.13B 68.13B 1.24B 8.75B 3.23B 27.96B 3.02B 2.95B 121B 822M 777M 721M 643M 1.16B 69.74B 1.27B 8.96B 3.31B 28.61B 3.09B 3.02B 124B
Net Debt 58.71M 55.49M 51.48M 45.91M 82.91M 4.98B 90.84M 640M 236M 2.04B 220M 216M 8.87B -693M -655M -608M -542M -979M -58.8B -1.07B -7.55B -2.79B -24.13B -2.6B -2.55B -105B
More financial data * Estimated data
Logo Hologic, Inc.
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows: - molecular diagnostics (46.7%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin; - breast health (35.5%): digital mammography and breast biopsy solutions and systems; - gynecological surgery (15%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures; - bone health (2.8%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment. Net sales break down by source of revenue between sales of products (81.4%) and services (18.6%). Net sales are distributed geographically as follows: the United States (75.9%), Europe (12.9%), Asia/Pacific (6.3%) and other (4.9%).
Employees
6,990
More about the company
Date Price Change Volume
10/12/24 77.09 $ +1.71% 2,133,940
09/12/24 75.79 $ +0.60% 2,326,179
06/12/24 75.34 $ -0.87% 1,356,781
05/12/24 76.00 $ -1.13% 1,630,306
04/12/24 76.87 $ -0.77% 2,094,084

Delayed Quote Nasdaq, December 10, 2024 at 05:12 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
surperformance-ratings-light-chart HOLOGIC-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
75.79USD
Average target price
87.33USD
Spread / Average Target
+15.22%
Consensus

Quarterly revenue - Rate of surprise